Suppr超能文献

吲哚胺2,3-双加氧酶1通过引发过量的氮氧化应激和铁蓄积加重对乙酰氨基酚诱导的急性肝衰竭。

Indoleamine 2, 3-dioxygenase 1 aggravates acetaminophen-induced acute liver failure by triggering excess nitroxidative stress and iron accumulation.

作者信息

Li Yunjia, Song Yuhong, Deng Guanghui, Tan Qinxiang, Xu Shu, Yang Menghan, Shi Hao, Hong Mukeng, Ye Haixin, Wu Chaofeng, Ma Shuoyi, Huang Huacong, Zhang Yanhong, Zeng Zhiyun, Wang Ming, Chen Yuyao, Wang Yunqing, Ma Jun, Li Juan, Gao Lei

机构信息

Zhujiang Hospital, Southern Medical University, Guangzhou, 510280, China; School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, 510000, Guangdong, China.

Shenzhen Hospital, Beijing University of Chinese Medicine, Shenzhen, 518116, Guangdong, China.

出版信息

Free Radic Biol Med. 2021 Aug 20;172:578-589. doi: 10.1016/j.freeradbiomed.2021.07.008. Epub 2021 Jul 6.

Abstract

Acetaminophen (APAP) is the leading cause of acute liver failure (ALF), which is characterized by GSH depletion, oxidative stress and mitochondrial dysfunction. However, the specific mechanism of APAP-induced ALF remains to be clarified. In this study, we demonstrated that indoleamine 2,3-dioxygenase 1 (IDO1) aggravated APAP-induced ALF associated with excess lipid peroxidation, which was reversed by lipid peroxidation inhibitor (ferrostatin-1). Meanwhile, IDO1 deficiency effectively decreased the accumulation of reactive nitrogen species. Additionally, IDO1 deficiency prevented against APAP-induced liver injury through suppressing the activation of macrophages, thereby reduced their iron uptake and export, eventually reduced iron accumulation in hepatocytes through transferrin and transferrin receptor axis. In summary, our study confirmed that APAP-induced IDO1 aggravated ALF by triggering excess oxidative and nitrative stress and iron accumulation in liver. These results offer new insights for the clinical treatment of ALF or iron-dysregulated liver diseases in the future.

摘要

对乙酰氨基酚(APAP)是急性肝衰竭(ALF)的主要病因,其特征为谷胱甘肽耗竭、氧化应激和线粒体功能障碍。然而,APAP诱导ALF的具体机制仍有待阐明。在本研究中,我们证明吲哚胺2,3-双加氧酶1(IDO1)加重了与过量脂质过氧化相关的APAP诱导的ALF,脂质过氧化抑制剂(铁抑素-1)可逆转这种情况。同时,IDO1缺乏有效减少了活性氮物质的积累。此外,IDO1缺乏通过抑制巨噬细胞的激活来预防APAP诱导的肝损伤,从而减少其铁摄取和输出,最终通过转铁蛋白和转铁蛋白受体轴减少肝细胞中的铁积累。总之,我们的研究证实,APAP诱导的IDO1通过引发肝脏中过量的氧化和硝化应激以及铁积累加重了ALF。这些结果为未来ALF或铁代谢失调性肝病的临床治疗提供了新的见解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验